These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 6424111
1. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H. Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7390-4. PubMed ID: 6424111 [Abstract] [Full Text] [Related]
2. Decreased biologic activity and degradation of human [SerB24]-insulin, a second mutant insulin. Haneda M, Kobayashi M, Maegawa H, Watanabe N, Takata Y, Ishibashi O, Shigeta Y, Inouye K. Diabetes; 1985 Jun; 34(6):568-73. PubMed ID: 3891469 [Abstract] [Full Text] [Related]
3. Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. Haneda M, Chan SJ, Kwok SC, Rubenstein AH, Steiner DF. Proc Natl Acad Sci U S A; 1983 Oct; 80(20):6366-70. PubMed ID: 6312455 [Abstract] [Full Text] [Related]
4. Lilly lecture 1983. Abnormal products of the human insulin gene. Tager HS. Diabetes; 1984 Jul; 33(7):693-9. PubMed ID: 6376225 [Abstract] [Full Text] [Related]
5. Two mutant forms of human insulin. Structural consequences of the substitution of invariant B24- or B25-phenylalanine by leucine. Wollmer A, Strassburger W, Glatter U, Dodson GG, McCall M, Gattner HG, Danho W, Brandenburg D, Rittel W. Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):581-91. PubMed ID: 7024084 [Abstract] [Full Text] [Related]
6. Mutations at the dimer, hexamer, and receptor-binding surfaces of insulin independently affect insulin-insulin and insulin-receptor interactions. Shoelson SE, Lu ZX, Parlautan L, Lynch CS, Weiss MA. Biochemistry; 1992 Feb 18; 31(6):1757-67. PubMed ID: 1737029 [Abstract] [Full Text] [Related]
7. Human insulin B24 (Phe----Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model. Shoelson SE, Polonsky KS, Zeidler A, Rubenstein AH, Tager HS. J Clin Invest; 1984 May 18; 73(5):1351-8. PubMed ID: 6371057 [Abstract] [Full Text] [Related]
8. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin. Kobayashi M, Haneda M, Maegawa H, Watanabe N, Takada Y, Shigeta Y, Inouye K. Biochem Biophys Res Commun; 1984 Feb 29; 119(1):49-57. PubMed ID: 6367745 [Abstract] [Full Text] [Related]
9. Semisynthesis and biological activity of porcine [LeuB24]insulin and [LeuB25]insulin. Tager H, Thomas N, Assoian R, Rubenstein A, Saekow M, Olefsky J, Kaiser ET. Proc Natl Acad Sci U S A; 1980 Jun 29; 77(6):3181-5. PubMed ID: 6997872 [Abstract] [Full Text] [Related]
10. Three mutant insulins in man. Shoelson S, Haneda M, Blix P, Nanjo A, Sanke T, Inouye K, Steiner D, Rubenstein A, Tager H. Nature; 1983 Apr 07; 302(5908):540-3. PubMed ID: 6339950 [Abstract] [Full Text] [Related]
11. Diabetes mellitus caused by mutations in human insulin: analysis of impaired receptor binding of insulins Wakayama, Los Angeles and Chicago using pharmacoinformatics. Islam MA, Bhayye S, Adeniyi AA, Soliman ME, Pillay TS. J Biomol Struct Dyn; 2017 Mar 07; 35(4):724-737. PubMed ID: 26950281 [Abstract] [Full Text] [Related]
12. Structural determinants of ligand recognition by type I insulin-like growth factor receptors: use of semisynthetic insulin analog probes. Cara JF, Nakagawa SH, Tager HS. Endocrinology; 1988 Jun 07; 122(6):2881-7. PubMed ID: 2967179 [Abstract] [Full Text] [Related]
13. Paradoxical structure and function in a mutant human insulin associated with diabetes mellitus. Hua QX, Shoelson SE, Inouye K, Weiss MA. Proc Natl Acad Sci U S A; 1993 Jan 15; 90(2):582-6. PubMed ID: 8421693 [Abstract] [Full Text] [Related]
14. Structure-function relationships of shortened [LeuB25]insulins, semisynthetic analogues of a mutant human insulin. Fischer WH, Saunders D, Brandenburg D, Diaconescu C, Wollmer A, Dodson G, De Meyts P, Zahn H. Biol Chem Hoppe Seyler; 1986 Sep 15; 367(9):999-1006. PubMed ID: 3539147 [Abstract] [Full Text] [Related]
15. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects. Nakagawa SH, Tager HS. J Biol Chem; 1986 Jun 05; 261(16):7332-41. PubMed ID: 3519607 [Abstract] [Full Text] [Related]
16. Insulin analogs with B24 or B25 phenylalanine replaced by biphenylalanine. Du H, Shi J, Cui D, Zhang Y. Acta Biochim Biophys Sin (Shanghai); 2008 Feb 05; 40(2):133-9. PubMed ID: 18235975 [Abstract] [Full Text] [Related]
17. Identification of a point mutation in the human insulin gene giving rise to a structurally abnormal insulin (insulin Chicago). Kwok SC, Steiner DF, Rubenstein AH, Tager HS. Diabetes; 1983 Sep 05; 32(9):872-5. PubMed ID: 6313457 [Abstract] [Full Text] [Related]
18. Structurally abnormal insulin in a diabetic patient. Characterization of the mutant insulin A3 (Val----Leu) isolated from the pancreas. Sakura H, Iwamoto Y, Sakamoto Y, Kuzuya T, Hirata H. J Clin Invest; 1986 Dec 05; 78(6):1666-72. PubMed ID: 3537011 [Abstract] [Full Text] [Related]
19. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). Clinical and functional characteristics of [LeuA3] insulin. Nanjo K, Sanke T, Miyano M, Okai K, Sowa R, Kondo M, Nishimura S, Iwo K, Miyamura K, Given BD. J Clin Invest; 1986 Feb 05; 77(2):514-9. PubMed ID: 3511099 [Abstract] [Full Text] [Related]
20. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Xu B, Hu SQ, Chu YC, Huang K, Nakagawa SH, Whittaker J, Katsoyannis PG, Weiss MA. Biochemistry; 2004 Jul 06; 43(26):8356-72. PubMed ID: 15222748 [Abstract] [Full Text] [Related] Page: [Next] [New Search]